166 related articles for article (PubMed ID: 31337851)
1. Anticancer properties of 5Z-(4-fluorobenzylidene)-2-(4-hydroxyphenylamino)-thiazol-4-one.
Szychowski KA; Kaminskyy DV; Leja ML; Kryshchyshyn AP; Lesyk RB; Tobiasz J; Wnuk M; Pomianek T; Gmiński J
Sci Rep; 2019 Jul; 9(1):10609. PubMed ID: 31337851
[TBL] [Abstract][Full Text] [Related]
2. Study of novel anticancer 4-thiazolidinone derivatives.
Szychowski KA; Leja ML; Kaminskyy DV; Binduga UE; Pinyazhko OR; Lesyk RB; Gmiński J
Chem Biol Interact; 2017 Jan; 262():46-56. PubMed ID: 27965178
[TBL] [Abstract][Full Text] [Related]
3. 4-thiazolidinone-based derivatives rosiglitazone and pioglitazone affect the expression of antioxidant enzymes in different human cell lines.
Szychowski KA; Skóra B; Kryshchyshyn-Dylevych A; Kaminskyy D; Khyluk D; Lesyk R
Biomed Pharmacother; 2021 Jul; 139():111684. PubMed ID: 34243632
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Anticancer and Antibacterial Activity of Four 4-Thiazolidinone-Based Derivatives.
Skóra B; Lewińska A; Kryshchyshyn-Dylevych A; Kaminskyy D; Lesyk R; Szychowski KA
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164157
[TBL] [Abstract][Full Text] [Related]
5. Pyrrolidinedione-thiazolidinone hybrid molecules with potent cytotoxic effect in squamous cell carcinoma SCC-15 cells.
Finiuk N; Kaleniuk E; Holota S; Stoika R; Lesyk R; Szychowski KA
Bioorg Med Chem; 2023 Sep; 92():117442. PubMed ID: 37579525
[TBL] [Abstract][Full Text] [Related]
6. 5-Arylidene-2-(4-hydroxyphenyl)aminothiazol-4(5H)-ones with selective inhibitory activity against some leukemia cell lines.
Subtelna I; Kryshchyshyn-Dylevych A; Jia R; Lelyukh M; Ringler A; Kubicek S; Zagrijtschuk O; Kralovics R; Lesyk R
Arch Pharm (Weinheim); 2021 Apr; 354(4):e2000342. PubMed ID: 33241558
[TBL] [Abstract][Full Text] [Related]
7. Anticancer properties of 4-thiazolidinone derivatives depend on peroxisome proliferator-activated receptor gamma (PPARγ).
Szychowski KA; Leja ML; Kaminskyy DV; Kryshchyshyn AP; Binduga UE; Pinyazhko OR; Lesyk RB; Tobiasz J; Gmiński J
Eur J Med Chem; 2017 Dec; 141():162-168. PubMed ID: 29031063
[TBL] [Abstract][Full Text] [Related]
8. New 4-thiazolidinone-based molecules Les-2769 and Les-3266 as possible PPARγ modulators.
Bar M; Skóra B; Tabęcka-Łonczyńska A; Holota S; Khyluk D; Roman O; Lesyk R; Szychowski KA
Bioorg Chem; 2022 Nov; 128():106075. PubMed ID: 35952447
[TBL] [Abstract][Full Text] [Related]
9. Trans-Resveratrol Induces Apoptosis through ROS-Triggered Mitochondria-Dependent Pathways in A549 Human Lung Adenocarcinoma Epithelial Cells.
Lucas IK; Kolodziej H
Planta Med; 2015 Aug; 81(12-13):1038-44. PubMed ID: 26085046
[TBL] [Abstract][Full Text] [Related]
10. Effect of fraxetin and myricetin on rotenone-induced cytotoxicity in SH-SY5Y cells: comparison with N-acetylcysteine.
Molina-Jimenez MF; Sanchez-Reus MI; Benedi J
Eur J Pharmacol; 2003 Jul; 472(1-2):81-7. PubMed ID: 12860476
[TBL] [Abstract][Full Text] [Related]
11. Combined treatment with peroxisome proliferator-activated receptor (PPAR) gamma ligands and gamma radiation induces apoptosis by PPARγ-independent up-regulation of reactive oxygen species-induced deoxyribonucleic acid damage signals in non-small cell lung cancer cells.
Han EJ; Im CN; Park SH; Moon EY; Hong SH
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):e239-48. PubMed ID: 23332223
[TBL] [Abstract][Full Text] [Related]
12. Loganin protects against hydrogen peroxide-induced apoptosis by inhibiting phosphorylation of JNK, p38, and ERK 1/2 MAPKs in SH-SY5Y cells.
Kwon SH; Kim JA; Hong SI; Jung YH; Kim HC; Lee SY; Jang CG
Neurochem Int; 2011 Mar; 58(4):533-41. PubMed ID: 21241762
[TBL] [Abstract][Full Text] [Related]
13. The variable chemotherapeutic response of Malabaricone-A in leukemic and solid tumor cell lines depends on the degree of redox imbalance.
Manna A; De Sarkar S; De S; Bauri AK; Chattopadhyay S; Chatterjee M
Phytomedicine; 2015 Jul; 22(7-8):713-23. PubMed ID: 26141757
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress mediated apoptosis induced by nickel ferrite nanoparticles in cultured A549 cells.
Ahamed M; Akhtar MJ; Siddiqui MA; Ahmad J; Musarrat J; Al-Khedhairy AA; AlSalhi MS; Alrokayan SA
Toxicology; 2011 May; 283(2-3):101-8. PubMed ID: 21382431
[TBL] [Abstract][Full Text] [Related]
15. Apoptotic action of peroxisome proliferator-activated receptor-gamma activation in human non small-cell lung cancer is mediated via proline oxidase-induced reactive oxygen species formation.
Kim KY; Ahn JH; Cheon HG
Mol Pharmacol; 2007 Sep; 72(3):674-85. PubMed ID: 17535976
[TBL] [Abstract][Full Text] [Related]
16. Anticancer activity study of A
Marucci G; Santinelli C; Buccioni M; Navia AM; Lambertucci C; Zhurina A; Yli-Harja O; Volpini R; Kandhavelu M
Life Sci; 2018 Jul; 205():155-163. PubMed ID: 29763615
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines.
Yoshizawa K; Cioca DP; Kawa S; Tanaka E; Kiyosawa K
Cancer; 2002 Nov; 95(10):2243-51. PubMed ID: 12412180
[TBL] [Abstract][Full Text] [Related]
18. Activation of peroxisome proliferator-activated receptor gamma contributes to the survival of T lymphoma cells by affecting cellular metabolism.
Yang C; Jo SH; Csernus B; Hyjek E; Liu Y; Chadburn A; Wang YL
Am J Pathol; 2007 Feb; 170(2):722-32. PubMed ID: 17255338
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells.
Hashimoto K; Ethridge RT; Evers BM
Int J Gastrointest Cancer; 2002; 32(1):7-22. PubMed ID: 12630765
[TBL] [Abstract][Full Text] [Related]
20. Erlotinib induces the human non-small-cell lung cancer cells apoptosis via activating ROS-dependent JNK pathways.
Shan F; Shao Z; Jiang S; Cheng Z
Cancer Med; 2016 Nov; 5(11):3166-3175. PubMed ID: 27726288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
